Literature DB >> 22535806

Continuous femoral nerve block versus patient-controlled analgesia following total knee arthroplasty.

Fu-Yuen Ng1, Kwong-Yuen Chiu, Chun Hoi Yan, Kwok-Fu Jacobus Ng.   

Abstract

PURPOSE: To compare total knee arthroplasty (TKA) patients who received continuous femoral nerve block (FNB) with local anaesthetics through a catheter versus patient-controlled analgesia (PCA) with intravenous morphine.
METHODS: 50 women and 10 men aged 51 to 84 years with matched characteristics underwent TKA and received either continuous FNB with local anaesthetics through a catheter (n=30) or PCA with intravenous morphine (n=30). None of the patients had had previous knee surgery. All operations were performed according to the standard protocol. Daily mean pain numerical rating scale at rest (NRS-R) and during movement (NRS-M), requirement of extra pain control, complications related to pain control, and overall patient satisfaction in both groups were compared.
RESULTS: Both groups were similar in terms of pain NRS-R and NRS-M, overall satisfaction, and length of hospital stay. Within each group, pain NRS-M score was significantly higher than pain NRS-R score. In the FNB group, 3 patients had dislodgement of the femoral catheter on day 1 and switched to PCA with intravenous morphine. Two of them had fair satisfaction. Patients in the PCA group had significantly more side-effects (nausea, vomiting, dizziness, and pruritis); 2 of the 5 patients with nausea and vomiting had fair satisfaction. No patients had any surgical complication.
CONCLUSION: Both FNC and PCA provide reliable pain control.

Entities:  

Mesh:

Year:  2012        PMID: 22535806     DOI: 10.1177/230949901202000105

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  8 in total

Review 1.  Perioperative pain control after total knee arthroplasty: An evidence based review of the role of peripheral nerve blocks.

Authors:  Thomas Danninger; Mathias Opperer; Stavros G Memtsoudis
Journal:  World J Orthop       Date:  2014-07-18

Review 2.  Femoral nerve blocks for acute postoperative pain after knee replacement surgery.

Authors:  Ee-Yuee Chan; Marlene Fransen; David A Parker; Pryseley N Assam; Nelson Chua
Journal:  Cochrane Database Syst Rev       Date:  2014-05-13

3.  The Chitranjan Ranawat Award: Periarticular injections and femoral & sciatic blocks provide similar pain relief after TKA: a randomized clinical trial.

Authors:  Mark J Spangehl; Henry D Clarke; Joseph G Hentz; Lopa Misra; Joshua L Blocher; David P Seamans
Journal:  Clin Orthop Relat Res       Date:  2015-01       Impact factor: 4.176

4.  Postoperative Ultrasound Guided Continuous Femoral Nerve Blockade for Unilateral Total Knee Arthroplasty: A Comparison of 0.125% Bupivacaine and 0.2% Ropivacaine.

Authors:  Sruthi C Babu; Gokuldas Menon; Bindu K Vasu; Mathew George; Jai Thilak; Sundaram Iyer
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

5.  Benefit of subcutaneous patient controlled analgesia after total knee arthroplasty.

Authors:  Yusuke Nakagawa; Toshifumi Watanabe; Yusuke Amano; Masafumi Horie; Tomomasa Nakamura; Koji Otabe; Mai Katakura; Ichiro Sekiya; Takeshi Muneta; Hideyuki Koga
Journal:  Asia Pac J Sports Med Arthrosc Rehabil Technol       Date:  2019-10-04

6.  Study on Main Drugs and Drug Combinations of Patient-Controlled Analgesia Based on Text Mining.

Authors:  Xing Jin; Ying Wu
Journal:  Pain Res Manag       Date:  2020-05-23       Impact factor: 3.037

7.  Effectiveness of Perineural Injections Combined with Standard Postoperative Total Knee Arthroplasty Protocols in the Management of Chronic Postsurgical Pain After Total Knee Arthroplasty.

Authors:  İsmail Güzel; Deniz Gül; Serkan Akpancar; John Lyftogt
Journal:  Med Sci Monit       Date:  2021-02-06

8.  Effectiveness of ERAS (Enhanced Recovery after Surgery) Protocol via Peripheral Nerve Block for Total Knee Arthroplasty.

Authors:  Hyun Hee Lee; Hyuck Min Kwon; Woo-Suk Lee; Ick Hwan Yang; Yong Seon Choi; Kwan Kyu Park
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.